CCM
BIIB icon

Canal Capital Management’s Biogen BIIB Stock Holding History

Canal Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,416
Closed -$854K – 112
2018
Q3 		$854K Buy
2,416
+10
+0.4% +$3.44K 0.49% 61
2018
Q2 		$698K Buy
2,406
+98
+4% +$27.6K 0.39% 71
2018
Q1 		$632K Sell
2,308
-456
-16% -$142K 0.36% 73
2017
Q4 		$881K Buy
2,764
+724
+35% +$232K 0.49% 56
2017
Q3 		$639K Buy
2,040
+194
+11% +$57.4K 0.38% 62
2017
Q2 		$501K Buy
1,846
+330
+22% +$87.3K 0.31% 75
2017
Q1 		$415K Buy
+1,516
New +$429K 0.28% 75

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Canal Capital Management's BIIB Position: Q4 2018 in Review

Canal Capital Management sold out of Biogen (BIIB) in Q4 2018, closing a stake of 2,416 shares — an estimated $854K sold.

Canal Capital Management first reported a position in BIIB in Q1 2017 and held it in 7 quarters. The position peaked at $881K in Q4 2017. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Canal Capital Management reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Canal Capital Management sold 2,416 Biogen shares in Q4 2018, an estimated $854K.
  • Canal Capital Management first reported a position in Biogen in Q1 2017 and held it in 7 quarters.
  • Canal Capital Management's Biogen position peaked at $881K in Q4 2017.
  • 1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Canal Capital Management's 13F filing for Q4 2018, filed 5 Feb 2019.